TQVAX — T. Rowe Price QM U.S. Value Equity Fund
Data updated: 2026-05-28
TQVAX — T. Rowe Price QM U.S. Value Equity Fund data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Large Cap Value Equity · $72.69M AUM · 0.99% expense ratio · 13.0% 1-yr return. From SEC regulatory filings.
TQVAX Fund Overview
TQVAX — T. Rowe Price QM U.S. Value Equity Fund is a US mutual fund managed by T. Rowe Price Integrated Equity Funds, Inc., categorised as United States Large Cap Value Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: T. Rowe Price Integrated Equity Funds, Inc.
- Category: United States Large Cap Value Equity
- Assets under management: $72.69M
- 1-year return: 13.0%
- Ticker: TQVAX
- SEC CIK: 0001038469
- SEC series ID: S000052905
- Share class ID: C000166443
TQVAX Holdings
Top 10 holdings of T. Rowe Price QM U.S. Value Equity Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Alphabet, Inc. Cl A | 3.64% |
| Berkshire Hathaway, Inc.-Cl B | 2.00% |
| Exxon Mobil Corp. | 1.91% |
| Bank Of America Corp. | 1.89% |
| J.p. Morgan Chase & Co. | 1.77% |
| Morgan Stanley | 1.62% |
| Micron Technology, Inc. | 1.53% |
| Gilead Sciences, Inc. | 1.42% |
| Caterpillar, Inc. | 1.41% |
| Lowe S Cos, Inc. | 1.39% |
TQVAX Portfolio Allocation
Asset-class allocation of T. Rowe Price QM U.S. Value Equity Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.7% |
| Cash & Equivalents | 0.2% |
TQVAX Performance
Total returns for TQVAX (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | 1.3% |
| 1 year | 13.0% |
| 3 years (annualised) | 14.4% |
| 5 years (annualised) | 9.9% |
TQVAX Risk Information
Risk metrics for TQVAX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 9.7%
TQVAX Costs and Fees
TQVAX costs about $99 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.99%
- Gross expense ratio: 2.33%
- Portfolio turnover: 88%
- Brokerage commissions: 2.08 bps of average net assets (SEC N-CEN)
TQVAX Cashflows
Over the 12 months to 2026-03, T. Rowe Price QM U.S. Value Equity Fund had net inflows of $3.08M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-03 | −$1.38M |
| 2026-02 | $4.66M |
| 2026-01 | $4.23M |
| 2025-12 | $5.47M |
| 2025-11 | $1.74M |
| 2025-10 | $949.36K |
TQVAX Debt Constituents
No individual debt constituents are reported in T. Rowe Price QM U.S. Value Equity Fund's latest SEC N-PORT filing.
TQVAX Prospectus and SEC Filings
Official T. Rowe Price QM U.S. Value Equity Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Large Cap Value Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.